ArticleBMC infectious diseases2026
Acceptability of HBV, HCV, and HIV screening among injured patients presenting to the adult emergency department in Blantyre, Malawi.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTrauma is among the leading causes of death and disability in Malawi and accounts for a substantial proportion of emergency admissions at tertiary hospitals. However, injured patients presenting for trauma care are infrequently screened for blood-borne viral infections, including hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV), resulting in missed opportunities for diagnosis and linkage to care. This study assessed the feasibility of finding new cases of HBV, HCV, and HIV among injured adult patients who presented to Queen Elizabeth Central Hospital (QECH) and evaluated the acceptability of provider-initiated opt-in testing.
methodsWe conducted a cross-sectional study from October to November 2021 among injured adults (n = 63) seeking trauma care at the Adult Emergency and Trauma Centre (AETC) of QECH in Blantyre, Malawi. Demographic data, risk factors, and injury characteristics were collected. Blood samples were tested for HBV, HCV, and HIV using SD BIOLINE HBsAg, Rapid Anti-HCV, and Determine HIV-1/2 rapid test kits, respectively and confirmed with enzyme-linked immunosorbent assay (ELISA). Case detection rate and testing acceptability were expressed as proportions.
resultsOf the 94 patients who were approached during the study period, 63 consented to participate in the study, representing a 67.02% acceptability of testing. Road traffic accident–related injuries accounted for 36.5% (n = 23) of the presentations, whereas non-traffic-related accidents accounted for the other 63.5%. Most refusals to participate in the study were due to fear of further blood loss and reluctance to undergo HIV testing. We found a total of 14 positive HIV cases within our study population, out of which 6 were newly diagnosed. Moreover, all cases of HBV (3 cases) and HCV (2 cases) were newly identified as well. HBV and HIV co-infection was observed in one participant.
conclusionA considerable proportion of injured patients presenting to the AETC had undiagnosed blood-borne viral infections, with reasonably high acceptability of testing. Incorporating routine HBV, HCV, and HIV provider-initiated testing into trauma care settings could improve early detection, linkages to care, and infection prevention strategies. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.